Back to Journals » Degenerative Neurological and Neuromuscular Disease » Volume 2

Emerging oral immunomodulating agents – focus on teriflunomide for the treatment of multiple sclerosis

Total article views   HTML views PDF downloads Totals
8,596 Dovepress* 8,596+ 2,695 11,291
Totals 8,596 2,695 11,291
*Since 13 March 2012
+Since July 2016

View citations on Google Scholar